Clinical Trials Browser

OTHER × Drug-Related Side Effects and Adverse Reactions × Nivolumab × Clear all

NCT05652673 2025-02-28

Safe Stop Ipilimumab-nivolumab (IPI-NIVO) Trial

Phase NA Recruiting

Melanoma, Drug-Related Side Effects and Adverse Reactions

NCT03638375 2023-12-12

ACTME

Phase 1/2 Unknown

Melanoma, Drug-Related Side Effects and Adverse Reactions